In this episode, I’ll discuss the consensus statement published in CHEST on the Treatment of Community-Acquired Pneumonia in immunocompromised patients. Subscribe on iTunes, Android, or Stitcher Authors in the journal CHEST published a consensus statement on the Treatment of Community-Acquired Pneumonia in immunocompromised patients. This patient population was left out of the updated IDSA CAP […]
Episode 855: Effect of phenylephrine push prior to continuous infusion norepinephrine in patients with septic shock
In this episode, I’ll discuss the effect of phenylephrine push prior to continuous infusion norepinephrine in patients with septic shock. Subscribe on iTunes, Android, or Stitcher Push dose vasopressors as a temporizing measure for profound hypotension in critically ill patients is frequently used in many institutions. However the extent of the data for this strategy […]
Episode 854: The Danger of Intubation in the Setting of Salicylate Toxicity
In this episode, I’ll discuss the danger of intubation in the setting of salicylate toxicity. Subscribe on iTunes, Android, or Stitcher During salicylate toxicity, the movement of salicylate into brain, liver, and other tissues is exacerbated by a low serum pH. This is because the more acidic the pH, the more salicylate becomes nonionized, and […]
Episode 853: Can hypotension from dexmedetomidine be predicted?
In this episode, I’ll discuss how to predict hypotension from dexmedetomidine. Subscribe on iTunes, Android, or Stitcher Dexmedetomidine is a popular sedative for use in critically ill patients. Hypotension is a common side effect that may limit the dose or even use of dexmedetomidine in critically ill patients. Being able to predict hypotension in advance […]
Episode 852: Does Europe Do Apixaban Renal Dosing Better (Safer) Than the US?
In this episode, I’ll discuss a study about the safety of apixaban in patients with renal insufficiency. Subscribe on iTunes, Android, or Stitcher The US FDA and the European Medicines Agency have discordant recommendations for apixaban dosing in chronic kidney disease. The US labeling states: Anti-FXa activity adjusted for exposure to apixaban was similar across […]
Episode 851: Why Is Racemic Epinephrine Nebulized To Help Treat Stridor?
In this episode, I’ll discuss how racemic epinephrine via nebulization is thought to help treat stridor. Subscribe on iTunes, Android, or Stitcher Stridor is an abnormal inspiratory sound and is a sign of airway obstruction that requires immediate attention. Stridor can be caused by a mass or foreign body in the upper airway, or by […]
Episode 850: A Pharmacy-Driven Rapid Bacteremia Response Program
In this episode, I’ll discuss a pharmacy-driven rapid bacteremia response program. Subscribe on iTunes, Android, or Stitcher While rapid diagnosis of bacteremia infections is wonderful, nothing matters until the patient actually receives effective antibiotic treatment. However the lag time between laboratory notification, physician order selection, pharmacy verification and dispensing, and nurse administration can be significant […]
Episode 849: Should apixaban’s loading dose duration ever be shortened?
In this episode, I’ll discuss whether apixaban’s loading dose duration should ever be shortened. Subscribe on iTunes, Android, or Stitcher A common clinical scenario in hospitals is the following: You have a patient with DVT or PE that has been on a therapeutic heparin infusion for several days, the physician wants to switch the patient […]
Episode 848: Treatment of norepinephrine extravasation
In this episode, I’ll discuss the treatment of norepinephrine extravasation. Subscribe on iTunes, Android, or Stitcher Central line access is often preferred for vasopressor administration due to the risk of extravasation. Extravasation of a vasopressor such as norepinephrine can cause tissue necrosis and ultimately, the loss of a limb due to local vasoconstriction. The terms […]
Episode 847: A Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients
In this episode, I’ll discuss a clinical prediction model for augmented renal clearance in adult mixed critically ill patients. Subscribe on iTunes, Android, or Stitcher Augmented or enhanced renal clearance is a phenomenon in some critically ill patients whereby their kidney function becomes supranormal. Awareness of clinicians to the possibility of augmented renal clearance in critically […]
Episode 846: A Massive Enoxaparin Overdose and How it Was Handled
In this episode, I’ll discuss a case report of enoxaparin overdose. Subscribe on iTunes, Android, or Stitcher A group of authors recently published their experience treating an overdose of 900 mg enoxaparin with a protamine bolus and infusion in the American Journal of Health System Pharmacy. There is little data available on managing large enoxaparin […]
Episode 845: How aggressively should extremely high blood pressure be managed in patients with ICH?
In this episode, I’ll discuss how aggressively extremely high blood pressure should be managed in patients with ICH. Subscribe on iTunes, Android, or Stitcher AHA guidelines for the management of spontaneous intracerebral hemorrhage (ICH) split hypertension management recommendations into two groups based on the strength of available evidence. The first group is those with a blood […]
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 83
- Next Page »